| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3296846 | Gastroenterology | 2010 | 13 Pages |
Abstract
Silymarin's ability to inhibit the proliferation and proinflammatory cytokine secretion of T cells, combined with its previously described antiviral effect, suggests a possible mechanism of action that could lead to clinical benefit during HCV infection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Chihiro Morishima, Margaret C. Shuhart, Chia C. Wang, Denise M. Paschal, Minjun C. Apodaca, Yanze Liu, Derek D. Sloan, Tyler N. Graf, Nicholas H. Oberlies, David Y.-W. Lee, Keith R. Jerome, Stephen J. Polyak,